Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-11-29

Clinical Trial Update: Impact of isoQUercetin and Aspirin on Platelet Function [NA]

View source ↗

Summary

A clinical trial investigating the effects of isoQUercetin and aspirin on platelet function in cardiovascular disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • Isoquercetin (isoquercetin)

Snippet

Sponsor: University of Reading | Conditions: Cardiovascular Disease | NA | Status: WITHDRAWN